Barclays Reiterates Equalweight Rating on GlaxoSmithKline (GSK)

April 10, 2019 3:21 AM EDT Send to a Friend
Barclays reiterated an Equalweight rating and GBP16.00 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login